Description
The Center for Disease Control and Prevention (CDC) is conducting market research to identify parties with the resources to support the acquisition of a Luminex Flexmap3D multiplexing instrument. The instrument will be used for measuring multiple proteins such as cytokines, chemokines, and various signaling pathway proteins from a small amount of blood, BAL, urine, or culture media. The CDC is looking for a vendor who can provide the instrument, installation, training, and technical support. The contract will include a 12-month warranty and a one-year full-service warranty. The vendor must comply with Section 508 accessibility standards.
• The Luminex Flexmap3D instrument must be able to distinguish a minimum of 1 to a maximum of 500 unique, preset bead spectral addresses within a single sample.
• The instrument must come with xPONENT 4.3 software and a range of ancillary equipment, including a keyboard, mouse, and power cables.
• The vendor must provide training and technical support, including a day of training with a specialist and unlimited scheduled trainings on vendor assays and the FM3D system.
• The contract will include a 12-month warranty and a one-year full-service warranty.
• The vendor must comply with Section 508 accessibility standards and provide an Accessibility Conformance Report (ACR) or a completed HHS Section 508 Accessibility Conformance Checklist.